InnoBation Bio
PrivateCompany Overview
InnoBation Bio is a biotechnology company that develops cancer biomarkers, antibody-based anti-cancer therapeutics, and CAR-T cell therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
CAR-T therapyimmunotherapycell therapyliquid biopsymonoclonal antibodyoncology pipelinecompanion diagnosticcancer biomarkerdrug discoverybiotech startupprecision medicineclinical developmentCDMOMALDI-TOF MS
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InnoBation Bio Comparables
Compare InnoBation Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IASO Bio | 85% | |
| Liminatus Pharma, Inc. | 84% | |
| ImmuneOncia Therapeutics | 81% | |
InnoBation Bio Funding Rounds
Historical fundraising activity
InnoBation Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about InnoBation Bio's valuation, stock price, and market status.
See something wrong or outdated?